COX-2 Selective NSAIDs Industry Research Report 2025

Summary

According to APO Research, the global COX-2 Selective NSAIDs market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for COX-2 Selective NSAIDs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for COX-2 Selective NSAIDs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for COX-2 Selective NSAIDs is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of COX-2 Selective NSAIDs include Teva, Merck, Mylan, Jiangsu Hengrui Medicine, Pfizer, Lupin and Apotex, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COX-2 Selective NSAIDs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COX-2 Selective NSAIDs.

The report will help the COX-2 Selective NSAIDs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.



The COX-2 Selective NSAIDs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global COX-2 Selective NSAIDs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

COX-2 Selective NSAIDs Segment by Company

Teva
Merck
Mylan
Jiangsu Hengrui Medicine
Pfizer
Lupin
Apotex
COX-2 Selective NSAIDs Segment by Type

Valdecoxib
Rofecoxib
Celecoxib
Etoricoxib
COX-2 Selective NSAIDs Segment by Application

Hospital
Clinic
Other
COX-2 Selective NSAIDs Segment by Region


North America
United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Middle East & Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global COX-2 Selective NSAIDs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of COX-2 Selective NSAIDs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of COX-2 Selective NSAIDs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of COX-2 Selective NSAIDs manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of COX-2 Selective NSAIDs by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of COX-2 Selective NSAIDs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 Global Market Growth Prospects
2.2.1 Global COX-2 Selective NSAIDs Market Size (2020-2031)
2.2.2 Global COX-2 Selective NSAIDs Sales (2020-2031)
2.2.3 Global COX-2 Selective NSAIDs Market Average Price (2020-2031)
2.3 COX-2 Selective NSAIDs by Type
2.3.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Valdecoxib
2.3.3 Rofecoxib
2.3.4 Celecoxib
2.3.5 Etoricoxib
2.4 COX-2 Selective NSAIDs by Application
2.4.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.4.2 Hospital
2.4.3 Clinic
2.4.4 Other
3 Market Competitive Landscape by Manufacturers
3.1 Global COX-2 Selective NSAIDs Market Competitive Situation by Manufacturers (2020 Versus 2024)
3.2 Global COX-2 Selective NSAIDs Sales (K Units) of Manufacturers (2020-2025)
3.3 Global COX-2 Selective NSAIDs Revenue of Manufacturers (2020-2025)
3.4 Global COX-2 Selective NSAIDs Average Price by Manufacturers (2020-2025)
3.5 Global COX-2 Selective NSAIDs Industry Ranking, 2023 VS 2024 VS 2025
3.6 Global Manufacturers of COX-2 Selective NSAIDs, Manufacturing Sites & Headquarters
3.7 Global Manufacturers of COX-2 Selective NSAIDs, Product Type & Application
3.8 Global Manufacturers of COX-2 Selective NSAIDs, Established Date
3.9 Global COX-2 Selective NSAIDs Market CR5 and HHI
3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Teva
4.1.1 Teva Company Information
4.1.2 Teva Business Overview
4.1.3 Teva COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2020-2025)
4.1.4 Teva COX-2 Selective NSAIDs Product Portfolio
4.1.5 Teva Recent Developments
4.2 Merck
4.2.1 Merck Company Information
4.2.2 Merck Business Overview
4.2.3 Merck COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2020-2025)
4.2.4 Merck COX-2 Selective NSAIDs Product Portfolio
4.2.5 Merck Recent Developments
4.3 Mylan
4.3.1 Mylan Company Information
4.3.2 Mylan Business Overview
4.3.3 Mylan COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2020-2025)
4.3.4 Mylan COX-2 Selective NSAIDs Product Portfolio
4.3.5 Mylan Recent Developments
4.4 Jiangsu Hengrui Medicine
4.4.1 Jiangsu Hengrui Medicine Company Information
4.4.2 Jiangsu Hengrui Medicine Business Overview
4.4.3 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2020-2025)
4.4.4 Jiangsu Hengrui Medicine COX-2 Selective NSAIDs Product Portfolio
4.4.5 Jiangsu Hengrui Medicine Recent Developments
4.5 Pfizer
4.5.1 Pfizer Company Information
4.5.2 Pfizer Business Overview
4.5.3 Pfizer COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2020-2025)
4.5.4 Pfizer COX-2 Selective NSAIDs Product Portfolio
4.5.5 Pfizer Recent Developments
4.6 Lupin
4.6.1 Lupin Company Information
4.6.2 Lupin Business Overview
4.6.3 Lupin COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2020-2025)
4.6.4 Lupin COX-2 Selective NSAIDs Product Portfolio
4.6.5 Lupin Recent Developments
4.7 Apotex
4.7.1 Apotex Company Information
4.7.2 Apotex Business Overview
4.7.3 Apotex COX-2 Selective NSAIDs Sales, Revenue and Gross Margin (2020-2025)
4.7.4 Apotex COX-2 Selective NSAIDs Product Portfolio
4.7.5 Apotex Recent Developments
5 Global COX-2 Selective NSAIDs Market Scenario by Region
5.1 Global COX-2 Selective NSAIDs Market Size by Region: 2020 VS 2024 VS 2031
5.2 Global COX-2 Selective NSAIDs Sales by Region: 2020-2031
5.2.1 Global COX-2 Selective NSAIDs Sales by Region: 2020-2025
5.2.2 Global COX-2 Selective NSAIDs Sales by Region: 2026-2031
5.3 Global COX-2 Selective NSAIDs Revenue by Region: 2020-2031
5.3.1 Global COX-2 Selective NSAIDs Revenue by Region: 2020-2025
5.3.2 Global COX-2 Selective NSAIDs Revenue by Region: 2026-2031
5.4 North America COX-2 Selective NSAIDs Market Facts & Figures by Country
5.4.1 North America COX-2 Selective NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
5.4.2 North America COX-2 Selective NSAIDs Sales by Country (2020-2031)
5.4.3 North America COX-2 Selective NSAIDs Revenue by Country (2020-2031)
5.4.4 United States
5.4.5 Canada
5.4.6 Mexico
5.5 Europe COX-2 Selective NSAIDs Market Facts & Figures by Country
5.5.1 Europe COX-2 Selective NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
5.5.2 Europe COX-2 Selective NSAIDs Sales by Country (2020-2031)
5.5.3 Europe COX-2 Selective NSAIDs Revenue by Country (2020-2031)
5.5.4 Germany
5.5.5 France
5.5.6 U.K.
5.5.7 Italy
5.5.8 Russia
5.5.9 Spain
5.5.10 Netherlands
5.5.11 Switzerland
5.5.12 Sweden
5.5.13 Poland
5.6 Asia Pacific COX-2 Selective NSAIDs Market Facts & Figures by Country
5.6.1 Asia Pacific COX-2 Selective NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
5.6.2 Asia Pacific COX-2 Selective NSAIDs Sales by Country (2020-2031)
5.6.3 Asia Pacific COX-2 Selective NSAIDs Revenue by Country (2020-2031)
5.6.4 China
5.6.5 Japan
5.6.6 South Korea
5.6.7 India
5.6.8 Australia
5.6.9 Taiwan
5.6.10 Southeast Asia
5.7 South America COX-2 Selective NSAIDs Market Facts & Figures by Country
5.7.1 South America COX-2 Selective NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
5.7.2 South America COX-2 Selective NSAIDs Sales by Country (2020-2031)
5.7.3 South America COX-2 Selective NSAIDs Revenue by Country (2020-2031)
5.7.4 Brazil
5.7.5 Argentina
5.7.6 Chile
5.8 Middle East and Africa COX-2 Selective NSAIDs Market Facts & Figures by Country
5.8.1 Middle East and Africa COX-2 Selective NSAIDs Market Size by Country: 2020 VS 2024 VS 2031
5.8.2 Middle East and Africa COX-2 Selective NSAIDs Sales by Country (2020-2031)
5.8.3 Middle East and Africa COX-2 Selective NSAIDs Revenue by Country (2020-2031)
5.8.4 Egypt
5.8.5 South Africa
5.8.6 Israel
5.8.7 Türkiye
5.8.8 GCC Countries
6 Segment by Type
6.1 Global COX-2 Selective NSAIDs Sales by Type (2020-2031)
6.1.1 Global COX-2 Selective NSAIDs Sales by Type (2020-2031) & (K Units)
6.1.2 Global COX-2 Selective NSAIDs Sales Market Share by Type (2020-2031)
6.2 Global COX-2 Selective NSAIDs Revenue by Type (2020-2031)
6.2.1 Global COX-2 Selective NSAIDs Sales by Type (2020-2031) & (US$ Million)
6.2.2 Global COX-2 Selective NSAIDs Revenue Market Share by Type (2020-2031)
6.3 Global COX-2 Selective NSAIDs Price by Type (2020-2031)
7 Segment by Application
7.1 Global COX-2 Selective NSAIDs Sales by Application (2020-2031)
7.1.1 Global COX-2 Selective NSAIDs Sales by Application (2020-2031) & (K Units)
7.1.2 Global COX-2 Selective NSAIDs Sales Market Share by Application (2020-2031)
7.2 Global COX-2 Selective NSAIDs Revenue by Application (2020-2031)
7.2.1 Global COX-2 Selective NSAIDs Sales by Application (2020-2031) & (US$ Million)
7.2.2 Global COX-2 Selective NSAIDs Revenue Market Share by Application (2020-2031)
7.3 Global COX-2 Selective NSAIDs Price by Application (2020-2031)
8 Value Chain and Sales Channels Analysis of the Market
8.1 COX-2 Selective NSAIDs Value Chain Analysis
8.1.1 COX-2 Selective NSAIDs Key Raw Materials
8.1.2 Raw Materials Key Suppliers
8.1.3 COX-2 Selective NSAIDs Production Mode & Process
8.2 COX-2 Selective NSAIDs Sales Channels Analysis
8.2.1 Direct Comparison with Distribution Share
8.2.2 COX-2 Selective NSAIDs Distributors
8.2.3 COX-2 Selective NSAIDs Customers
9 Global COX-2 Selective NSAIDs Analyzing Market Dynamics
9.1 COX-2 Selective NSAIDs Industry Trends
9.2 COX-2 Selective NSAIDs Industry Drivers
9.3 COX-2 Selective NSAIDs Industry Opportunities and Challenges
9.4 COX-2 Selective NSAIDs Industry Restraints
10 Report Conclusion
11 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings